Temporary Cushing's syndrome from percutaneous absorption of betamethasone 17-valerate.
D001623:Betamethasone / Q000009:adverse effects*; D003480:Cushing Syndrome / Q000139:chemically induced*; D012628:Dermatitis, Seborrheic / Q000188:drug therapy; D005260:Female; D006801:Humans; D007223:Infant; D012869:Skin Absorption; D013997:Time Factors; D014631:Valerates / Q000009:adverse effects
D014631:Valerates; D001623:Betamethasone